M9657, a novel tumor-targeted conditional anti-CD137 agonist displays MSLN-dependent anti-tumor immunity
CD137/FAP Agonist | InOncology – Boehringer Ingelheim
![PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b38f2f0bf049aa78ec4687809f0b3029dda16b7/2-Figure1-1.png "PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar")
PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar
CD137 and CD137L Immune Checkpoints for Immuno-oncology Research from Adipogen Life Sciences
Early signal transduction events from CD137. Schematic representation... | Download Scientific Diagram
The effects of inhibition of CD137-CD137L interaction by antagonistic... | Download Scientific Diagram
CD137: An Important Target in T Cell Co-Stimulation
Immunotherapy Screening - CD137:CD137L pathway - Tebubio's blog
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity. - Abstract - Europe PMC
Cancers | Free Full-Text | CD137+ T-Cells: Protagonists of the Immunotherapy Revolution
Cells | Free Full-Text | The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
Frontiers | CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
![PDF] The Roles of CD137 Signaling in Atherosclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b7016aaf410b47a8f196028053fd7a21c7cc507d/5-Figure1-1.png "PDF] The Roles of CD137 Signaling in Atherosclerosis | Semantic Scholar")
PDF] The Roles of CD137 Signaling in Atherosclerosis | Semantic Scholar
Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells | Cancer Communications | Full Text
Regulation of CD137 and CD137L expression. Activation of APCs via... | Download Scientific Diagram
Cancers | Free Full-Text | CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
Mechanism of accelerated CD137-and CD137L-mediated signaling in... | Download Scientific Diagram
Rationale for anti-CD137 cancer immunotherapy - ScienceDirect
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications
Anticorps CD137 (BBK-2) | SCBT - Santa Cruz Biotechnology
Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy - Sanchez‐Paulete - 2016 - European Journal of Immunology - Wiley Online Library
CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling | Cancer Cell International | Full Text
CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice | Circulation
